Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.
about
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coliIn vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanismsResistance to linezolid caused by modifications at its binding site on the ribosomeInduced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivityStructural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus.Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomesRetapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophilaCharacterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis.The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.The good, the bad and the tasty: The many roles of mushrooms.Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance.Are pleuromutilin antibiotics finally fit for human use?In vitro antibacterial activity of NB-003 against Propionibacterium acnes.Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.Topical retapamulin in the management of infected traumatic skin lesions.Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolatesInvestigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage studyNovel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.In Vitro Activity of Retapamulin against Staphylococcus aureus Resistant to Various Antimicrobial Agents.In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaLinezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center.Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.Cellular pharmacokinetics and intracellular activity of gepotidacin against Staphylococcus aureus with different resistance phenotypes in models of cultured phagocytic cells.
P2860
Q24627750-CC056563-FB33-4396-94F0-04824FBC60B3Q24653865-F7115BC7-4326-475F-ABF9-E6400014F2C6Q27006772-64D2AB32-C5F4-4F4C-8187-F096EF1EC90BQ27644059-4E40C089-282C-4548-96ED-5AF079C5CC07Q34497915-DF5A9638-9E0F-4ADC-B646-018CA4A9101DQ34570427-027B87CB-7FC0-4C70-8A4F-2973592F1F0FQ34580239-1255E430-7323-4D59-9CCE-E9587D6932F7Q34585413-54E09133-754C-4BE5-9CEB-5A25BE636B32Q34618656-61B7488C-448F-4A2C-B3E7-BE346010BFAEQ36094925-16B5E36D-E07F-45C5-B800-45BAABD3D999Q36578817-74DF81D5-3131-4639-AC7D-6CB97F4E3566Q36699496-681B81C6-8429-4F6B-BAD1-864CD8911235Q37432080-9DA74C2B-5464-4E43-9398-A36CC074FE1CQ37570744-D2FB0E26-AC25-434D-814B-6108E38AACE1Q37713002-4531E821-7765-4036-AB52-9EE6D06C9505Q37835585-EFC62B0E-973A-46E0-A9F6-5B54772BE04AQ37970720-DAB64177-DA6E-4702-96CB-DC2C99748778Q38283280-915FA87B-33D0-4CBD-A5AB-2BA8D5AA80E2Q38546598-FACF449A-0E67-4A58-97BD-ADD9AAD9C9E8Q38673550-6929AA2B-939D-48D4-8EA6-57069CC4C3EAQ41435804-6B9C1A67-896F-44D2-BA93-5D5051D1727AQ41818471-E16E76DB-D7C9-4EE0-9F81-F8CD4167C2C4Q41897387-B0FF79F5-38AE-4E27-A8DE-19CDA528609CQ41967244-B9AB6B7E-650C-459E-B72A-A44D0A746DF9Q42009908-4863C621-D389-4DA0-88F0-C8B7FDB729BEQ42024058-177FCE44-80C3-417C-A939-FB1CADC6CCEFQ42111061-0DDAE509-63E9-47F0-91B0-89D4D43CAF48Q42572976-979482C9-14B7-4499-837D-91C6FFF2DA91Q42727109-E98595E3-F6C9-4260-9DF3-C4A247E7A782Q43183363-1F56E0A8-BEC5-4FB9-8F43-4F0EBDEC83C4Q43251094-F1B4E03F-B397-4847-A85C-DE52146D4D6DQ49874631-801D86DE-BE31-4304-8030-E4C58ED1305C
P2860
Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@ast
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@en
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@nl
type
label
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@ast
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@en
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@nl
prefLabel
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@ast
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@en
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@nl
P2093
P2860
P1476
Single- and multistep resistan ...... us and Streptococcus pyogenes.
@en
P2093
Bonifacio Dewasse
Catherine Clark
Kim Credito
Klaudia Kosowska-Shick
Pamela McGhee
Peter C Appelbaum
Tatiana Bogdanovich
P2860
P304
P356
10.1128/AAC.50.2.765-769.2006
P407
P577
2006-02-01T00:00:00Z